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Background
Analysis of immunoglobulin (Ig) VH and VL genes
derived from sorted single B cells is a powerful technology
for definition of Ig repertoires to viral infections. The pur-
pose of this study was to characterize the Ig repertoire of
plasma cells/plasmablasts (PCs) in subjects early on after
HIV transmission.
Methods
Blood PCs from three AHI subjects obtained approxi-
mately 17, 20 and 30 days after HIV-1 transmission were
sorted into 96-well plates for amplification of VH and VL
genes by RT/PCR. The isolated VH and VL genes were
expressed as recombinant IgG1 mAbs in 293T cells by
transfection using linear Ig expression cassettes, The spe-
cificity of produced mAbs was determined by ELISA and
luminex bead immunoassays against a panel of HIV-1 and
non-HIV-1 antigens.
Results
The number of circulating plasma cells ranged from 1.9%
to 21.0%. When HIV antibodies were detected in subject
plasma, only antibodies to Env gp41 were present. A total
of 787 Ig VH and VL gene pairs were expressed as whole
IgG1 antibodies. HIV-specific antibodies accounted for
only 6.5% of expressed antibodies (range 1.7% to 19%).
All HIV-1 antibodies were against gp41 with no antibod-
ies reacting with any other HIV-1 proteins. Non-HIV-1
antibodies identified from AHI PCs included those
against influenza (0.6%), tetanus toxoid (1.9%), cardioli-
pin (0.8%), Cryptococcus (0.9%), Candida (0.5%), Hep-
2 epithelial cells (5.2%), gut flora (1.7%), lipid A (0.6%)
and unknown (79.3%).
Conclusion
While the initial plasma cell response to influenza vacci-
nation was primarily antigen specific against hemaggluti-
nin, the initial plasma cell response to HIV-1 was
primarily polyclonal with massive expansion of non-HIV
antibodies. The extraordinary degree of polyclonal B cell
activation as early as 17 days after transmission is in part
responsible for the ineffective initial antibody response to
transmitted HIV.
from AIDS Vaccine 2009
Paris, France. 19–22 October 2009
Published: 22 October 2009
Retrovirology 2009, 6(Suppl 3):P73 doi:10.1186/1742-4690-6-S3-P73
<supplement> <title> <p>AIDS Vaccine 2009</p> </title> <editor>Anna Laura Ross</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1742-4690-6-S3-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1471-2105-10-S12-info.pdf</url> </supplement>
This abstract is available from: http://www.retrovirology.com/content/6/S3/P73
© 2009 Liao et al; licensee BioMed Central Ltd. 
